Conjunctivitis treatment market projected to reach $6.13B by 2030

Nov. 20, 2026
Conjunctivitis treatment market projected to reach $6.13B by 2030
By AI, Created 14:45 UTC, Nov 20, 2026, AGP -

The global conjunctivitis treatment market is set to grow from $5.1 billion in 2026 to $6.13 billion by 2030, according to The Business Research Company. Growth is being driven by rising eye-infection cases, an aging population, and wider access to over-the-counter eye care products, with Asia-Pacific expected to post the fastest gains.

Why it matters: - The conjunctivitis treatment market is expanding as more people seek care for eye infections and allergy-related irritation. - The growth outlook points to stronger demand for topical medicines, over-the-counter eye care products, and home-based treatment options. - An aging global population is adding to the need for treatment, since older adults face higher risk of eye-related conditions.

What happened: - The Business Research Company published its Conjunctivitis Treatment Global Market Report 2026 covering market size, trends, and forecasts through 2035. - The market is projected to rise from $4.89 billion in 2025 to $5.1 billion in 2026. - The report forecasts the market will reach $6.13 billion by 2030, equal to a 4.7% compound annual growth rate. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - The historical growth outlook reflects high prevalence of eye infections, exposure to bacterial and viral agents, limited access to specialized ophthalmic care, widespread use of topical antibiotics, and seasonal allergies. - The forecast period is supported by rising awareness of eye hygiene, more self-medication, broader availability of over-the-counter ophthalmic products, growing urban populations, and better access to eye care services. - Expected product trends include preservative-free eye drops, combination drug therapies, broader use of OTC treatments, faster symptom relief, and home-based care. - Conjunctivitis treatment covers medical approaches used to relieve symptoms and address the causes of pink eye. - The report’s geographic coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The report says 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report sample is available here. - The full report is available here.

Between the lines: - The aging-population driver is especially important because the UK’s 65-and-over population reached 12.7 million in 2022, or 19% of the population, and is projected to rise to 22.1 million, or 27%, by 2072. - That demographic shift signals sustained demand for eye-care treatment over the long term, not just a short-term bump. - The Asia-Pacific growth outlook suggests future market gains are likely to be tied to population growth, urbanization, and expanding access to care.

What’s next: - Market demand is likely to track adoption of OTC ophthalmic products and preservative-free formulations. - Treatment providers and manufacturers will likely focus on faster symptom relief and easier at-home use. - Regional competition is expected to intensify as Asia-Pacific outpaces other markets in growth.

The bottom line: - Conjunctivitis treatment is a steady-growth market, with demographics, self-care trends, and broader access to eye products driving the next phase of expansion.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.